Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Shanghai Sigma Audley SSA.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 83 | 99.66% | Sep 18, 2026 |
| Tirzepatide | 44 | 99.74% | May 6, 2026 |
| Tesamorelin | 23 | 94.99% | Sep 18, 2026 |
| BPC-157 | 14 | 95.65% | Aug 3, 2026 |
| GHK-Cu | 11 | 99.91% | May 5, 2026 |
| Cagrilintide | 10 | 98.59% | Jan 7, 2026 |
| Semaglutide | 10 | 99.57% | Mar 3, 2026 |
| Sermorelin | 8 | 98.89% | Feb 20, 2026 |
| Ipamorelin | 8 | 99.72% | Feb 20, 2026 |
| PT-141 | 5 | 99.61% | Oct 23, 2025 |
| Melanotan II | 5 | 99.44% | Sep 14, 2026 |
| TB-500 | 3 | 64.54% | Sep 9, 2025 |
| CJC-1295 No DAC | 3 | 98.3% | Oct 23, 2025 |
| CJC-1295 | 1 | 98.78% | Jul 31, 2025 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Tesamorelin | 8-5-26/8-5-26 | n/a | Lab E | Sep 18, 2026 | verify |
| Retatrutide | 8-5-26/8-5-28 | n/a | Lab E | Sep 18, 2026 | verify |
| Melanotan II | 8-5-26/8-5-28 | n/a | Lab E | Sep 14, 2026 | verify |
| BPC-157 | SABC1020250718D | 98.5% | Lab E | Aug 3, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | May 6, 2026 | verify |
| GHK-Cu | n/a | 99.9% | Lab E | May 5, 2026 | verify |
| Retatrutide | 41528 | 99.9% | Lab E | May 5, 2026 | verify |
| Melanotan II | n/a | 99.9% | Lab G | Mar 29, 2026 | verify |
| Tirzepatide | n/a | 99.8% | Lab G | Mar 25, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab G | Mar 25, 2026 | verify |
| Tesamorelin | SATSM10202507280 | 99.7% | Lab E | Mar 19, 2026 | verify |
| Retatrutide | SART1520250728F | 99.9% | Lab E | Mar 19, 2026 | verify |
| Retatrutide | SART6020250728W | 99.9% | Lab E | Mar 18, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Mar 10, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Mar 10, 2026 | verify |
| Retatrutide | SART520250728W | 99.9% | Lab E | Mar 10, 2026 | verify |
| Melanotan II | n/a | 98.5% | Lab E | Mar 6, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Mar 4, 2026 | verify |
| Tirzepatide | n/a | 98.95% | Lab E | Mar 4, 2026 | verify |
| Semaglutide | n/a | 99.85% | Lab E | Mar 3, 2026 | verify |
| Retatrutide | SAR3020250718w | 99.62% | Lab E | Mar 3, 2026 | verify |
| Retatrutide | n/a | 99.5% | Lab E | Mar 3, 2026 | verify |
| Sermorelin | Serm-10 blue cap 12212025 | 98.99% | Lab E | Feb 20, 2026 | verify |
| GHK-Cu | ABC-ghk50-12122025 | 99.9% | Lab E | Feb 20, 2026 | verify |
| Ipamorelin | Mfg 12052025 | 99.62% | Lab E | Feb 20, 2026 | verify |
Showing 25 most recent of 228. Search the full database on the CoA page.
Sell or represent Shanghai Sigma Audley SSA? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/shanghai-sigma-audley-ssa/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/shanghai-sigma-audley-ssa.svg" alt="Shanghai Sigma Audley SSA: lab tested, 228 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.